Dashboard
Manage Tickers

JNJ JOHNSON & JOHNSON

NYSE jnj.com


$ 190.32 $ 0.00 (0 %)    

Wednesday, 15-Oct-2025 05:39:22 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 603.00 $ 0.00 (0 %)
DIA $ 464.73 $ 0.00 (0 %)
SPY $ 666.18 $ 0.00 (0 %)
TLT $ 91.00 $ 0.00 (0 %)
GLD $ 385.90 $ 0.00 (0 %)
$ 190.85
$ 193.60
$ 190.06 x 101
$ 190.34 x 5
-- - --
$ 137.37 - $ 194.40
13,613,340
na
459.63B
$ 0.34
$ 20.28
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-24-2025 06-29-2025 10-Q
2 04-23-2025 03-30-2025 10-Q
3 02-13-2025 12-29-2024 10-K
4 10-23-2024 09-29-2024 10-Q
5 07-25-2024 06-30-2024 10-Q
6 05-01-2024 03-31-2024 10-Q
7 02-16-2024 12-31-2023 10-K
8 10-27-2023 10-01-2023 10-Q
9 10-27-2023 10-01-2023 10-Q
10 07-31-2023 07-02-2023 10-Q
11 04-28-2023 04-02-2023 10-Q
12 02-16-2023 01-01-2023 10-K
13 10-27-2022 10-02-2022 10-Q
14 07-29-2022 07-03-2022 10-Q
15 04-29-2022 04-03-2022 10-Q
16 02-17-2022 01-02-2022 10-K
17 10-29-2021 10-03-2021 10-Q
18 07-29-2021 07-04-2021 10-Q
19 04-30-2021 04-04-2021 10-Q
20 02-22-2021 01-03-2021 10-K
21 10-23-2020 09-27-2020 10-Q
22 07-24-2020 06-28-2020 10-Q
23 04-29-2020 03-29-2020 10-Q
24 02-18-2020 12-29-2019 10-K
25 10-28-2019 09-29-2019 10-Q
26 07-29-2019 06-30-2019 10-Q
27 05-01-2019 03-31-2019 10-Q
28 02-20-2019 12-30-2018 10-K
29 10-31-2018 09-30-2018 10-Q
30 08-02-2018 07-01-2018 10-Q
31 05-01-2018 04-01-2018 10-Q
32 02-21-2018 12-31-2017 10-K
33 11-02-2017 10-01-2017 10-Q
34 08-03-2017 07-02-2017 10-Q
35 05-08-2017 04-02-2017 10-Q
36 02-27-2017 01-01-2017 10-K
37 11-04-2016 10-02-2016 10-Q
38 08-04-2016 07-03-2016 10-Q
39 05-10-2016 04-03-2016 10-Q
40 02-24-2016 01-03-2016 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

looking-at-johnson--johnsons-recent-unusual-options-activity
Looking At Johnson & Johnson's Recent Unus...
10/14/2025 19:01:48

ubs-maintains-buy-on-johnson--johnson-raises-price-target-to-214
UBS Maintains Buy on Johnson & Johnson, Ra...
10/14/2025 16:06:49

UBS analyst Danielle Antalffy maintains Johnson & Johnson (NYSE:JNJ) with a Buy and raises the price target from $190 to...

johnson--johnson-cfo-joseph-wolk-says-2026-adj-eps-expected-to-exceed-current-street-estimates-by-as-much-as-5-cents
Johnson & Johnson CFO Joseph Wolk Says 202...
10/14/2025 13:14:19

- Conf Call

johnson--johnson-cfo-joseph-wolk-says-expect-rulings-on-certain-legal-motions-pending-in-talc-litigation-by-q1-2026-says-2026-revenue-growth-in-total-expected-to-exceed-5-above-current-street-estimates
Johnson & Johnson CFO Joseph Wolk Says Exp...
10/14/2025 13:12:09

- Conf Call

johnson--johnson-to-separate-orthopedics-business-boosts-annual-sales-outlook
Johnson & Johnson To Separate Orthopedics ...
10/14/2025 12:51:28

Johnson & Johnson beats Q3 estimates, raises 2025 sales guidance, and announces plans to spin off its $9.2 billion orthoped...

stock-market-today-dow-jones-nasdaq-futures-tumble-ahead-of-big-bank-earningsgoldman-sachs-jpmorgan-citigroup-in-focus-updated
Stock Market Today: Dow Jones, Nasdaq Futu...
10/14/2025 12:24:14

Editor’s Note: The future prices of benchmark tracking ETFs, the lede, and the latest economic releases were updated in the sto...

johnson--johnson-intends-to-separate-its-orthopedics-business-and-establish-a-standalone-business-operating-as-depuy-synthes
Johnson & Johnson Intends To Separate Its ...
10/14/2025 10:27:26

Strengthens focus of Johnson & Johnson as an innovation powerhouse and accelerates the portfolio shift of its MedTech Segme...

johnson--johnson-affirms-fy2025-adj-eps-guidance-of-1080-1090-vs-1087-est-raises-fy2025-sales-guidance-from-93200b-93600b-to-93500b-93900b-vs-93436b-est
Johnson & Johnson Affirms FY2025 Adj EPS G...
10/14/2025 10:24:06

($ in Billions, except EPS)October 2025July 2025Adjusted Operational Sales1,2,5Change vs. Prior Year / Mid-point3.5% – 4.0% / 3...

johnson--johnson-q3-2025-adj-eps-280-beats-275-estimate-sales-23993b-beat-23741b-estimate
Johnson & Johnson Q3 2025 Adj. EPS $2.80 B...
10/14/2025 10:20:57

Core News & Articles
Earnings Scheduled For October 14, 2025
10/14/2025 08:32:10

goldman-sachs-jpmorgan-chase-and-3-stocks-to-watch-heading-into-tuesday
Goldman Sachs, JPMorgan Chase And 3 Stocks...
10/14/2025 06:17:11

US stock futures lower, focus on Goldman Sachs, JPMorgan, Polaris, Johnson & Johnson, and Citigroup earnings.

atai-life-sciences-remains-undervalued-analyst-initiates-with-around-125-stock-upside
Atai Life Sciences Remains Undervalued, An...
10/13/2025 18:21:17

Atai Life Sciences' BPL-003 shows strong Phase 2b results for treatment-resistant depression, with potential $2.5 billion s...

johnson--johnson-q3-preview-with-stock-near-all-time-highs-heres-what-to-watch
Johnson & Johnson Q3 Preview: With Stock N...
10/13/2025 16:27:44

Johnson & Johnson stock trades near all-time highs with an upcoming Q3 earnings report acting as the next catalyst.

fda-adds-new-warning-for-johnson--johnsons-cancer-cell-therapy
FDA Adds New Warning For Johnson & Johnson...
10/13/2025 14:30:41

FDA updates Johnson & Johnson's Carvykti label to warn of rare immune-related enterocolitis while reaffirming the thera...

a-peek-at-johnson--johnsons-future-earnings
A Peek at Johnson & Johnson's Future Earnings
10/13/2025 14:00:50

retail-investors-top-stocks-with-earnings-this-week-fastenal-asml-tsmc-and-more
Retail Investors' Top Stocks With Earnings...
10/13/2025 12:01:42

Retail investors are preparing for the kick-off of the Q3 earnings season, with big banks and other top stocks reporting this w...

fda-approves-labeling-changes-including-boxed-warning-for-immune-effector-cell-associated-enterocolitis-after-treatment-with-ciltacabtagene-autoleucel--determined-overall-benefit-of-carvykti-continues-to-outweigh-potential-risks-for-approved-use
FDA Approves Labeling Changes Including Bo...
10/10/2025 21:32:27

https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-approves-labeling-changes-include-boxed-warning-...

johnson--johnson-warns-shareholders-to-reject-mini-tender-offer-by-tutanota-to-purchase-up-to-500k-shares-of-the-companys-common-stock-at-a-price-of-14500share-in-cash
Johnson & Johnson Warns Shareholders To Re...
10/10/2025 20:22:57

Johnson & Johnson (NYSE:JNJ) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LL...

morgan-stanley-maintains-equal-weight-on-johnson--johnson-raises-price-target-to-178
Morgan Stanley Maintains Equal-Weight on J...
10/10/2025 17:38:25

Morgan Stanley analyst Terence Flynn maintains Johnson & Johnson (NYSE:JNJ) with a Equal-Weight and raises the price tar...

johnson--johnson-in-talks-to-acquire-protagonist-therapeutics-report
Johnson & Johnson In Talks To Acquire Prot...
10/10/2025 17:06:05

Johnson & Johnson is in talks to buy Protagonist Therapeutics in a deal that could expand its immunology and cancer drug po...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION